Randomized, Double-Masked, Active-Controlled, Phase 3 Study of the Efficacy and Safety of Aflibercept 8 mg in Macular Edema Secondary to Retinal Vein Occlusion.
Mihai Mititelu
Peripheral Exudative Hemorrhagic Chorioretinopathy (PEHCR): Diagnostic and Therapeutic Challenges.
PubMed ID: 37763626 Author(s): Elwood KF, Richards PJ, Schildroth KR, Mititelu M. Peripheral Exudative Hemorrhagic Chorioretinopathy (PEHCR): Diagnostic and Therapeutic Challenges. Medicina (Kaunas). 2023 Aug 22;59(9):1507. doi: 10.3390/medicina59091507. PMID 37763626 Journal: Medicina (Kaunas, Lithuania), Volume …
Retinal thickness and morphology changes on OCT in youth with Type 2 Diabetes: Findings from the TODAY study.
PubMed ID: 36531589 Author(s): Mititelu M, Uschner D, Doherty L, Bjornstad P, Domalpally A, Drews KL, Gubitosi-Klug R, Levitsky LL, Pak JW, White NH, Blodi BA. Retinal thickness and morphology changes on OCT in youth …
Retinal thickness and morphology changes on OCT in youth with Type 2 Diabetes: Findings from the TODAY study.
PubMed ID: 36531589 Author(s): Mititelu M, Uschner D, Doherty L, Bjornstad P, Domalpally A, Drews KL, Gubitosi-Klug R, Levitsky LL, Pak JW, White NH, Blodi BA. Retinal thickness and morphology changes on OCT in youth …
Purtscher-like retinopathy with cardioembolic stroke: case report and literature review.
PubMed ID: 36466061 Author(s): Elwood KF, Dieu AC, Kuranz CV, Mititelu M. Purtscher-like retinopathy with cardioembolic stroke: case report and literature review. Case Rep Ophthalmol. 2022 Nov 17;13(3):943-948. doi: 10.1159/000527038. eCollection 2022 Sep-Dec. PMID 36466061 …
Purtscher-like retinopathy with cardioembolic stroke: case report and literature review.
PubMed ID: 36466061 Author(s): Elwood KF, Dieu AC, Kuranz CV, Mititelu M. Purtscher-like retinopathy with cardioembolic stroke: case report and literature review. Case Rep Ophthalmol. 2022 Nov 17;13(3):943-948. doi: 10.1159/000527038. eCollection 2022 Sep-Dec. PMID 36466061 …
The obesity paradox: Retinopathy, obesity, and circulating risk markers in youth with type 2 diabetes in the TODAY Study.
PubMed ID: 36150365 Author(s): Levitsky LL, Drews KL, Haymond M, Glubitosi-Klug RA, Levitt Katz LE, Mititelu M, Tamborlane W, Tryggestad JB, Weinstock RS; TODAY Study Group. The obesity paradox: Retinopathy, obesity, and circulating risk markers …
The obesity paradox: Retinopathy, obesity, and circulating risk markers in youth with type 2 diabetes in the TODAY Study.
PubMed ID: 36150365 Author(s): Levitsky LL, Drews KL, Haymond M, Glubitosi-Klug RA, Levitt Katz LE, Mititelu M, Tamborlane W, Tryggestad JB, Weinstock RS; TODAY Study Group. The obesity paradox: Retinopathy, obesity, and circulating risk markers …
GALE
To assess the long-term efficacy and safety of multiple intravitreal injections of APL-2 in subjects with geographic atrophy secondary to age-related macular degeneration.